We are live on ! Find out more
MDVX

Medovex Corp. Common Stock
MDVX

Delisted

MDVX was delisted on the 15th of November, 2017.

8 hedge funds and large institutions have $100K invested in Medovex Corp. Common Stock in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 68 (+2)

22% more capital invested

Capital invested by funds: $82K → $100K (+$18K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MIC
1
Meridian Investment Counsel
California
$52K +$62.4K +50,000 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$16K +$18.8K +15,093 New
Citadel Advisors
3
Citadel Advisors
Florida
$13K -$2.94K -2,358 -16%
MHS
4
M Holdings Securities
Oregon
$13K
UBS Group
5
UBS Group
Switzerland
$3K -$54.5K -43,686 -94%
BFA
6
BlackRock Fund Advisors
California
$3K +$577 +462 +23%
Morgan Stanley
7
Morgan Stanley
New York
-$2 -2 -11%

MDVX Hedge Fund Activity: Q1 2016 in Review

8 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q1 2016, worth a combined $100K — up 22% from $82K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MDVX positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Meridian Investment Counsel, opening a new position worth an estimated $62.4K. The largest seller was UBS Group, cutting an estimated $54.5K.

  • 8 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q1 2016, up from 6 in Q4 2015.
  • Funds reported $100K of Medovex Corp. Common Stock stock for Q1 2016, up 22% quarter-over-quarter.
  • 2 funds opened new Medovex Corp. Common Stock positions in Q1 2016 and 0 closed out, a net change of +2 holders.
  • The largest Medovex Corp. Common Stock buyer in Q1 2016 was Meridian Investment Counsel, an estimated $62.4K added.
  • The largest Medovex Corp. Common Stock seller in Q1 2016 was UBS Group, an estimated $54.5K sold.

Based on aggregated 13F filings for Q1 2016.